Omega Pharma (Nazareth) Overview

  • Year Founded
  • 1987

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2,500

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 18

Omega Pharma (Nazareth) General Information

Description

Developer and manufacturer of health and personal care products. The company offers products for face and body, sun care products and baby-specific products under the brand names Bodysol/Galenco, ACO, Lactacyd, Claire Fisher, Bergasol and Biodermal and medicated skin care products for various skin conditions and allergies under the Dermalex, Septivon and Wartner brands.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Industrial Zoning De Prijkels
  • Venecoweg 26
  • 9810 Nazareth
  • Belgium
Primary Industry
Personal Products
Other Industries
Medical Supplies
Acquirer
Corporate Office
  • Industrial Zoning De Prijkels
  • Venecoweg 26
  • 9810 Nazareth
  • Belgium

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Omega Pharma (Nazareth) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Omega Pharma (Nazareth)‘s full profile, request access.

Request a free trial

Omega Pharma (Nazareth) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Omega Pharma (Nazareth) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Omega Pharma (Nazareth)‘s full profile, request access.

Request a free trial

Omega Pharma (Nazareth) Investments & Acquisitions (18)

Omega Pharma (Nazareth)’s most recent deal was a Buyout/LBO with DesPharma. The deal was made on 16-Jul-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
DesPharma 16-Jul-2014 Buyout/LBO Other Healthcare Services
Pharco (Arterin Business) 28-Feb-2013 Buyout/LBO Food Products
Terra Sante 31-Jan-2011 Merger/Acquisition Other Commercial Services
Laboratorios Inibsa (Over The Counter Activities) 23-Dec-2010 Merger/Acquisition Personal Products
Laboratoire de la Mer 20-Oct-2010 Merger/Acquisition Pharmaceuticals
You’re viewing 5 of 18 investments and acquisitions. Get the full list »

Omega Pharma (Nazareth) Exits (7)

Omega Pharma (Nazareth)’s most recent exit was on 16-Nov-2007 from Ecuphar. The exit was categorized as with 4 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Ecuphar 16-Nov-2007 Completed
  • 4 buyers
Bittner Pharma 24-Oct-2006 Completed
ACO Hud Nordic 03-Sep-2004 Completed
Claire Fischer 01-Jun-2004 Completed
Hydroxydase 01-Jan-2004 Merger/Acquisition Completed
You’re viewing 5 of 7 exits. Get the full list »

Omega Pharma (Nazareth) Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
DesPharma Van Koetsveldstraat, Netherlands 2004
Laboratoire de la Mer Saint-Malo, France 1988

Omega Pharma (Nazareth) FAQs

  • When was Omega Pharma (Nazareth) founded?

    Omega Pharma (Nazareth) was founded in 1987.

  • Where is Omega Pharma (Nazareth) headquartered?

    Omega Pharma (Nazareth) is headquartered in Nazareth, Belgium.

  • What is the size of Omega Pharma (Nazareth)?

    Omega Pharma (Nazareth) has 2,500 total employees.

  • What industry is Omega Pharma (Nazareth) in?

    Omega Pharma (Nazareth)’s primary industry is Personal Products.

  • Is Omega Pharma (Nazareth) a private or public company?

    Omega Pharma (Nazareth) is a Private company.

  • What is the current valuation of Omega Pharma (Nazareth)?

    The current valuation of Omega Pharma (Nazareth) is .

  • What is Omega Pharma (Nazareth)’s current revenue?

    The current revenue for Omega Pharma (Nazareth) is .

  • Who are Omega Pharma (Nazareth)’s investors?

    Couckinvest, HarbourVest Partners, and Waterland Private Equity Investments have invested in Omega Pharma (Nazareth).

  • When was Omega Pharma (Nazareth) acquired?

    Omega Pharma (Nazareth) was acquired on 30-Mar-2015.

  • Who acquired Omega Pharma (Nazareth)?

    Omega Pharma (Nazareth) was acquired by Perrigo Company.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process